SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Katharine M. Esselen, Shu-Kay Ng, Yuanyuan Hua, Miranda White, Cynthia A. Jimenez, William R. Welch, Ronny Drapkin, Ross S. Berkowitz, Shu-Wing Ng, Endosalpingiosis as it relates to tubal, ovarian and serous neoplastic tissues: An immunohistochemical study of tubal and Müllerian antigens, Gynecologic Oncology, 2014, 132, 2, 316

    CrossRef

  2. 2
    Ren-Chin Wu, Ayse Ayhan, Daichi Maeda, Kyu-Rae Kim, Blaise A Clarke, Patricia Shaw, Michael Herman Chui, Barry Rosen, Ie-Ming Shih, Tian-Li Wang, Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy, The Journal of Pathology, 2014, 232, 4
  3. 3
    Feng Rao, Jiyoung Cha, Jing Xu, Risheng Xu, M. Scott Vandiver, Richa Tyagi, Robert Tokhunts, Michael A. Koldobskiy, Chenglai Fu, Roxanne Barrow, Mingxuan Wu, Dorothea Fiedler, James C. Barrow, Solomon H. Snyder, Inositol Pyrophosphates Mediate the DNA-PK/ATM-p53 Cell Death Pathway by Regulating CK2 Phosphorylation of Tti1/Tel2, Molecular Cell, 2014, 54, 1, 119

    CrossRef

  4. 4
    Laura Ardighieri, Felix Zeppernick, Charlotte G Hannibal, Russell Vang, Leslie Cope, Jette Junge, Susanne K Kjaer, Robert J Kurman, Ie-Ming Shih, Mutational analysis of BRAF and KRAS in ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implants, The Journal of Pathology, 2014, 232, 1
  5. 5
    Niloofar N. Nik, Russell Vang, Ie-Ming Shih, Robert J. Kurman, Origin and Pathogenesis of Pelvic (Ovarian, Tubal, and Primary Peritoneal) Serous Carcinoma, Annual Review of Pathology: Mechanisms of Disease, 2014, 9, 1, 27

    CrossRef

  6. 6
    Sabita N. Saldanha, Trygve O. Tollefsbol, Pathway Modulations and Epigenetic Alterations in Ovarian Tumorbiogenesis, Journal of Cellular Physiology, 2014, 229, 4
  7. 7
    Rachel N. Grisham, Gopa Iyer, Karuna Garg, Deborah DeLair, David M. Hyman, Qin Zhou, Alexia Iasonos, Michael F. Berger, Fanny Dao, David R. Spriggs, Douglas A. Levine, Carol Aghajanian, David B. Solit, BRAF Mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer , Cancer, 2013, 119, 3
  8. 8
    Sahar Pakneshan, Ali Salajegheh, Robert Anthony Smith, Alfred King-Yin Lam, Clinicopathological relevance of BRAF mutations in human cancer, Pathology, 2013, 45, 4, 346

    CrossRef

  9. 9
    Hans Bösmüller, Anna Fischer, Deborah L. Pham, Tanja Fehm, David Capper, Andreas von Deimling, Irina Bonzheim, Annette Staebler, Falko Fend, Detection of the BRAF V600E mutation in serous ovarian tumors: a comparative analysis of immunohistochemistry with a mutation-specific monoclonal antibody and allele-specific PCR, Human Pathology, 2013, 44, 3, 329

    CrossRef

  10. 10
    Chris MJ Conklin, C Blake Gilks, Differential diagnosis and clinical relevance of ovarian carcinoma subtypes, Expert Review of Obstetrics & Gynecology, 2013, 8, 1, 67

    CrossRef

  11. 11
    Anni Niskakoski, Sippy Kaur, Laura Renkonen-Sinisalo, Heini Lassus, Heikki J. Järvinen, Jukka-Pekka Mecklin, Ralf Bützow, Päivi Peltomäki, Distinct molecular profiles in Lynch syndrome-associated and sporadic ovarian carcinomas, International Journal of Cancer, 2013, 133, 11
  12. 12
    I. Kinde, C. Bettegowda, Y. Wang, J. Wu, N. Agrawal, I.-M. Shih, R. Kurman, F. Dao, D. A. Levine, R. Giuntoli, R. Roden, J. R. Eshleman, J. P. Carvalho, S. K. N. Marie, N. Papadopoulos, K. W. Kinzler, B. Vogelstein, L. A. Diaz, Evaluation of DNA from the Papanicolaou Test to Detect Ovarian and Endometrial Cancers, Science Translational Medicine, 2013, 5, 167, 167ra4

    CrossRef

  13. 13
    Katherine Stemke-Hale, Kristy Shipman, Isidora Kitsou-Mylona, David G de Castro, Vicky Hird, Robert Brown, James Flanagan, Hani Gabra, Gordon B Mills, Roshan Agarwal, Mona El-Bahrawy, Frequency of mutations and polymorphisms in borderline ovarian tumors of known cancer genes, Modern Pathology, 2013, 26, 4, 544

    CrossRef

  14. 14
    Yvonne T Tsang, Michael T Deavers, Charlotte C Sun, Suet-Yan Kwan, Eric Kuo, Anais Malpica, Samuel C Mok, David M Gershenson, Kwong-Kwok Wong, KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma, The Journal of Pathology, 2013, 231, 4
  15. 15
    Ignacio Romero, Charlotte C. Sun, Kwong K. Wong, Robert C. Bast, David M. Gershenson, Low-grade serous carcinoma: New concepts and emerging therapies, Gynecologic Oncology, 2013, 130, 3, 660

    CrossRef

  16. You have free access to this content16
    Ananta Gurung, Tawny Hung, Jason Morin, C Blake Gilks, Molecular abnormalities in ovarian carcinoma: clinical, morphological and therapeutic correlates, Histopathology, 2013, 62, 1
  17. 17
    Wen-Chih Huang, Chien-Chen Tsai, Ming-Chow Wei, Kuan-Ting Kuo, Mutation analysis of papillary tubal hyperplasia associated with ovarian atypical proliferative serous tumor and low-grade serous carcinoma, American Journal of Obstetrics and Gynecology, 2013, 209, 2, e6

    CrossRef

  18. 18
    Daichi Maeda, Ie-Ming Shih, Pathogenesis and the Role of ARID1A Mutation in Endometriosis-related Ovarian Neoplasms, Advances In Anatomic Pathology, 2013, 20, 1, 45

    CrossRef

  19. 19
    N Panupinthu, S Yu, D Zhang, F Zhang, M Gagea, Y Lu, J R Grandis, S E Dunn, H Y Lee, G B Mills, Self-reinforcing loop of amphiregulin and Y-box binding protein-1 contributes to poor outcomes in ovarian cancer, Oncogene, 2013,

    CrossRef

  20. 20
    Alon D Altman, Gregg S Nelson, Prafull Ghatage, John B McIntyre, David Capper, Pamela Chu, Jill G Nation, Anthony N Karnezis, Guangming Han, Steve E Kalloger, Martin Köbel, The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors, Modern Pathology, 2013, 26, 9, 1255

    CrossRef

  21. 21
    Constanze Zeller, Wei Dai, Edward Curry, Afshan Siddiq, Andrew Walley, Nahal Masrour, Isidora Kitsou-Mylona, Gail Anderson, Sadaf Ghaem-Maghami, Robert Brown, Mona El-Bahrawy, The DNA Methylomes of Serous Borderline Tumors Reveal Subgroups With Malignant- or Benign-Like Profiles, The American Journal of Pathology, 2013, 182, 3, 668

    CrossRef

  22. 22
    Assaf Vestin, Alea A. Mills, The tumor suppressor Chd5 is induced during neuronal differentiation in the developing mouse brain, Gene Expression Patterns, 2013, 13, 8, 482

    CrossRef

  23. 23
    Jeff Boyd, Biao Luo, Suraj Peri, Beth Wirchansky, Lucinda Hughes, Caitlin Forsythe, Hong Wu, Whole exome sequence analysis of serous borderline tumors of the ovary, Gynecologic Oncology, 2013, 130, 3, 560

    CrossRef

  24. 24
    Hiroaki Itamochi, Junzo Kigawa, Clinical trials and future potential of targeted therapy for ovarian cancer, International Journal of Clinical Oncology, 2012, 17, 5, 430

    CrossRef

  25. 25
    Ahmed N. AL-Niaimi, Mostafa Ahmed, Chase B. Petersen, Epithelial Ovarian Cancer, Obstetrics and Gynecology Clinics of North America, 2012, 39, 2, 269

    CrossRef

  26. 26
    E. Kuhn, R.-C. Wu, B. Guan, G. Wu, J. Zhang, Y. Wang, L. Song, X. Yuan, L. Wei, R. B. S. Roden, K.-T. Kuo, K. Nakayama, B. Clarke, P. Shaw, N. Olvera, R. J. Kurman, D. A. Levine, T.-L. Wang, I.-M. Shih, Identification of Molecular Pathway Aberrations in Uterine Serous Carcinoma by Genome-wide Analyses, JNCI Journal of the National Cancer Institute, 2012, 104, 19, 1503

    CrossRef

  27. 27
    Jim Jinn-Chyuan Sheu, Bin Guan, Fuu-Jen Tsai, Erin Yi-Ting Hsiao, Chih-Mei Chen, Raquel Seruca, Tian-Li Wang, Ie-Ming Shih, Mutant BRAF Induces DNA Strand Breaks, Activates DNA Damage Response Pathway, and Up-Regulates Glucose Transporter-1 in Nontransformed Epithelial Cells, The American Journal of Pathology, 2012, 180, 3, 1179

    CrossRef

  28. 28
    J. Prat, New insights into ovarian cancer pathology, Annals of Oncology, 2012, 23, suppl 10, x111

    CrossRef

  29. 29
    Jaime Prat, Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features, Virchows Archiv, 2012, 460, 3, 237

    CrossRef